In June, the Deutschen Gesellschaft für Wundheilung und Wundbehandlung e. V. (DGfW) published the S3 guideline „Lokaltherapie chronischer Wunden bei den Risiken CVI, PAVK und Diabetes mellitus“. The editors argue that, for the approval of wound dressings, no clinical proof is required in controlled studies. Therefore, there are very few studies which are based on high quality evidence, since the superiority of individual wound products are not yet be properly substantiated.
Therefore, the S3 guideline concludes that the physician should make their decision in the selection of materials according to patient comfort, wound management, cost and individual experiences.
[ilink url=“http://www.aerztezeitung.de/medizin/krankheiten/haut-krankheiten/article/819851/chronische-wunden-wundversorgung-zwischen-evidenz-erfahrung.html“]Link zur Quelle (Ärztezeitung)[/ilink]